Abstract
Background and aims
The adjuvant management of locally advanced rectal cancer has been the subject of much debate over the past 10 years. Whilst it is now widely accepted that combined chemoradiation therapy is the treatment of choice for adjuvant therapy following resection of high-risk tumours, there is still no clear answer on the sequencing of the two modalities in the postoperative setting.
Patients and methods
Soon after the NCI in the United States issued its recommendations on the management of resected rectal cancer, we decided to commence a phase 2 study to collect data prospectively on the toxicity of postoperative combined chemoradiation therapy. Radiation therapy was given early in combination with bolus chemotherapy using 5-fluorouracil (n=80). The prescribed radiation dose was 50.4 Gy in 28 fractions, and the chemotherapy was 450 mg/m2 given with fractions 1 – 3 and 26 – 28. On completion of the radiation therapy the patient was given a further four cycles of bolus 5-fluorouracil at monthly intervals. The patients were then closely monitored for side effects from the therapy and for signs of local and distant relapse.
Results
Acute toxicity of the therapy was significant, with 16% of patients experiencing severe bowel morbidity. The other major side effects of the therapy were skin reactions, neutropenia and bladder problems. Late bowel toxicity was also severe. The local in field relapse rate was 10%. The majority of relapses were at distant sites, mostly in the liver and lungs. The actuarial survival at 5 years was 55%.
Conclusion
We conclude that the combined adjuvant postoperative chemoradiation therapy using this protocol is effective but has significant acute and late morbidity. The optimum regimen for those patients requiring postoperative adjuvant therapy is yet to be determined.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Thomas PRM, Lindblad AS (1988) Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumour Study Group experience. Radiother Oncol 13:245–252
Balslev I, Pedersen M, Teglbjaerg PS, et al (1986) Postoperative radiotherapy in Dukes B and C carcinoma of the rectum and rectosigmoid. Cancer 58:22–28
Treuniet-Donker AD, Van Putten WLJ, Wereldsma JCJ, et al (1991) Postoperative radiotherapy for rectal cancer: an interim analysis of a prospective randomised multicentre trial in the Netherlands. Cancer 67:2042–2048
Fisher B, Wolmark N, Rockette H, et al (1988) Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from the NSABP Protocol R-01. J Natl Cancer Inst 80:21–29
Gastrointestinal Tumour Study Group (1985) Prolongation of the disease-free interval in surgically treated rectal cancer. N Engl J Med 312:1465–1472
Krook JE, Moertel CG, Gunderson LL, et al (1991) Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med 324:709–715
National Institutes of Health Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444–1460
Miller AB, Hoogstraten B, Staquet M, et al (1981) Reporting the results of cancer treatment. Cancer 47:207–214
Rubin P, Constine LS, Fajardo L, et al (1995) Overview: late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 31:1041–1042
Pavy JJ, Denekamp J, Letschert J, et al (1995) EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 35:11–15
Stevens G, Firth I, Solomon M, et al (2000) Rectal cancer: changing patterns of referral for radiation therapy 1982–1997. Aust NZ J Surg 70: 553–559
MacFarlane JK, Ryall RDH, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341:457 –460
Wolmark N, Wieand S, Hyams DM, et al (2000) Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 92:388–396
Frykholm GJ, Glimelius B, Pahlman L (1993) Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36:564–572
Rich TA, Skibber JM, Ajani JA, et al (1995) Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 32:1025–1029
Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980–987
Lee JH, Lee JH, Ahn JH, et al (2002) Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report. J Clin Oncol 20:1751–1758
O' Connell MJ, Martenson JA, Wieand HS, et al (1994) Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy for high risk rectal cancer. N Engl J Med 331:502–507
Chen FC, Mackay JR, Woods RJ, et al (1995) Early experience with postoperative adjuvant chemoradiation for rectal cancer: focus on morbidity. Aust NZ J Surg 65:732–736
Moore HC, Haller DG (1999) Adjuvant therapy of colon cancer. Semin Oncol 26:545–555
Acknowledgements
We acknowledge all the surgeons who referred patients for entry on to this study. In addition, we appreciate all the work done by the staff of the Queensland Radium Institute in compiling this report.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burmeister, B.H., Schache, D., Burmeister, E.A. et al. Synchronous postoperative adjuvant chemoradiation therapy for locally advanced carcinoma of the rectum. Int J Colorectal Dis 19, 55–59 (2004). https://doi.org/10.1007/s00384-003-0497-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-003-0497-9